134 related articles for article (PubMed ID: 28541957)
1. THE CUTTING EDGE OF RETINOPATHY OF PREMATURITY CARE: Expanding the Boundaries of Diagnosis and Treatment.
Yonekawa Y; Thomas BJ; Thanos A; Todorich B; Drenser KA; Trese MT; Capone A
Retina; 2017 Dec; 37(12):2208-2225. PubMed ID: 28541957
[TBL] [Abstract][Full Text] [Related]
2. Hot Topics in Retinopathy of Prematurity.
Tsui I; Chu A
Pediatr Ann; 2017 Nov; 46(11):e415-e422. PubMed ID: 29131921
[TBL] [Abstract][Full Text] [Related]
3. Role of VEGF Inhibition in the Treatment of Retinopathy of Prematurity.
Eldweik L; Mantagos IS
Semin Ophthalmol; 2016; 31(1-2):163-8. PubMed ID: 26959143
[TBL] [Abstract][Full Text] [Related]
4. New insights in diagnosis and treatment for Retinopathy of Prematurity.
Cernichiaro-Espinosa LA; Olguin-Manriquez FJ; Henaine-Berra A; Garcia-Aguirre G; Quiroz-Mercado H; Martinez-Castellanos MA
Int Ophthalmol; 2016 Oct; 36(5):751-60. PubMed ID: 26767656
[TBL] [Abstract][Full Text] [Related]
5. The association between systemic vascular endothelial growth factor and retinopathy of prematurity in premature infants: a systematic review.
Kandasamy Y; Hartley L; Rudd D; Smith R
Br J Ophthalmol; 2017 Jan; 101(1):21-24. PubMed ID: 27388246
[TBL] [Abstract][Full Text] [Related]
6. Five years of treatment for retinopathy of prematurity in Sweden: results from SWEDROP, a national quality register.
Holmström G; Hellström A; Jakobsson P; Lundgren P; Tornqvist K; Wallin A
Br J Ophthalmol; 2016 Dec; 100(12):1656-1661. PubMed ID: 26969711
[TBL] [Abstract][Full Text] [Related]
7. Pathophysiology, screening and treatment of ROP: A multi-disciplinary perspective.
Chan-Ling T; Gole GA; Quinn GE; Adamson SJ; Darlow BA
Prog Retin Eye Res; 2018 Jan; 62():77-119. PubMed ID: 28958885
[TBL] [Abstract][Full Text] [Related]
8. Evolving Concepts in the Management of Retinopathy of Prematurity.
Sternberg P; Durrani AK
Am J Ophthalmol; 2018 Feb; 186():xxiii-xxxii. PubMed ID: 29109051
[TBL] [Abstract][Full Text] [Related]
9. Reactivation of retinopathy of prematurity after ranibizumab treatment.
Wong RK; Hubschman S; Tsui I
Retina; 2015 Apr; 35(4):675-80. PubMed ID: 25768252
[TBL] [Abstract][Full Text] [Related]
10. Effects and complications of bevacizumab use in patients with retinopathy of prematurity: a multicenter study in taiwan.
Wu WC; Yeh PT; Chen SN; Yang CM; Lai CC; Kuo HK
Ophthalmology; 2011 Jan; 118(1):176-83. PubMed ID: 20673589
[TBL] [Abstract][Full Text] [Related]
11. Vitreous levels of angiopoietin-1 and angiopoietin-2 in eyes with retinopathy of prematurity.
Sato T; Shima C; Kusaka S
Am J Ophthalmol; 2011 Feb; 151(2):353-7.e1. PubMed ID: 21168819
[TBL] [Abstract][Full Text] [Related]
12. An evidence-based meta-analysis of vascular endothelial growth factor inhibition in pediatric retinal diseases: part 1. Retinopathy of prematurity.
Mititelu M; Chaudhary KM; Lieberman RM
J Pediatr Ophthalmol Strabismus; 2012; 49(6):332-40. PubMed ID: 22938516
[TBL] [Abstract][Full Text] [Related]
13. The Characteristics and Short-term Refractive Error Outcomes of Cystoid Macular Edema in Premature Neonates as Detected by Spectral-Domain Optical Coherence Tomography.
Bondalapati S; Milam RW; Ulrich JN; Cabrera MT
Ophthalmic Surg Lasers Imaging Retina; 2015 Sep; 46(8):806-12. PubMed ID: 26431295
[TBL] [Abstract][Full Text] [Related]
14. Fluorescein angiography of aggressive posterior retinopathy of prematurity treated with intravitreal anti-VEGF in large preterm babies.
Park SW; Jung HH; Heo H
Acta Ophthalmol; 2014 Dec; 92(8):810-3. PubMed ID: 24909062
[No Abstract] [Full Text] [Related]
15. Vascular endothelial growth factor antagonist therapy for retinopathy of prematurity.
Hartnett ME
Clin Perinatol; 2014 Dec; 41(4):925-43. PubMed ID: 25459781
[TBL] [Abstract][Full Text] [Related]
16. [Outcomes of surgical management of retinopathy of prematurity--an overview].
Kuprjanowicz L; Kubasik-Kładna K; Modrzejewska M
Klin Oczna; 2014; 116(2):138-41. PubMed ID: 25345295
[TBL] [Abstract][Full Text] [Related]
17. Current and future trends in treatment of severe retinopathy of prematurity.
Wallace DK; Wu KY
Clin Perinatol; 2013 Jun; 40(2):297-310. PubMed ID: 23719311
[TBL] [Abstract][Full Text] [Related]
18. Insulin-like growth factor-1 and anti-vascular endothelial growth factor in retinopathy of prematurity: has the time come?
Stahl A; Hellstrom A; Smith LE
Neonatology; 2014; 106(3):254-60. PubMed ID: 25300950
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of intravitreal bevacizumab for zone-II retinopathy of prematurity.
Karkhaneh R; Khodabande A; Riazi-Eafahani M; Roohipoor R; Ghassemi F; Imani M; Dastjani Farahani A; Ebrahimi Adib N; Torabi H
Acta Ophthalmol; 2016 Sep; 94(6):e417-20. PubMed ID: 27009449
[TBL] [Abstract][Full Text] [Related]
20. [Advances in Retinopathy of Prematurity].
Xu XX; Wu YJ; Wu HY; Hu YX; Cheng Y; Yan L; Rao J; Wu N; Wu XR
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2019 Apr; 41(2):261-266. PubMed ID: 31060684
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
